Harrow Health Inc(HROW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HROW Harrow Health Inc

盘前交易 03-23 04:43:13 EDT

33.28

-1.13

-3.28%

最高34.85	最低33.05	成交量101.01万
今开34.32	昨收34.41	日振幅5.23%
总市值12.39亿	流通市值9.06亿	总股本3,723万
成交额3,388万	换手率3.71%	流通股本2,723万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HROW","market":"US","secType":"STK","nameCN":"Harrow Health Inc","latestPrice":33.28,"timestamp":1774036800000,"preClose":34.41,"halted":0,"volume":1010114,"delay":0,"changeRate":-0.032839290903806904,"floatShares":27229209,"shares":37229705,"eps":-0.14,"marketStatus":"盘前交易","change":-1.13,"latestTime":"03-23 04:43:13 EDT","open":34.32,"high":34.8488,"low":33.05,"amount":33877802.329602,"amplitude":0.052276,"askPrice":33.65,"askSize":40,"bidPrice":32.58,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-0.14,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774272600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1360299600000,"exchange":"NASDAQ","adjPreClose":33.28,"postHourTrading":{"tag":"盘后","latestPrice":33.45,"preClose":33.28,"latestTime":"18:50 EDT","volume":80702,"amount":2686331.1188,"timestamp":1774047031571,"change":0.17,"changeRate":0.005108,"amplitude":0.021334},"volumeRatio":1.484391301680069,"impliedVol":0.5802,"impliedVolPercentile":0.196},"requestUrl":"/m/hq/s/HROW","defaultTab":"news","newsList":[{"id":"1145420319","title":"异动解读 | 哈罗制药预计全年收入低于预期，盘中大跌19.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145420319","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145420319?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:46","pubTimestamp":1772549183,"startTime":"0","endTime":"0","summary":"眼科药品制造商哈罗制药（Harrow Health Inc，股票代码：HROW）今日盘中股价大跌19.59%，引起了市场的广泛关注。消息面上，该公司发布了2026年全年收入指引，预计收入在3.5亿美元至3.65亿美元之间，这一数字低于分析师平均预期的3.8625亿美元。不及预期的业绩展望是导致股价下跌的主要原因。尽管该公司第四季度营收为8910万美元，略高于市场预期的8845万美元，但疲弱的全年预测盖过了季度业绩的积极影响，打击了投资者信心，从而在盘中交易中引发了抛售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HROW"],"gpt_icon":0},{"id":"1144435426","title":"Harrow将启动三期临床试验，寻求将Triesence®适应症扩展至白内障术后眼部炎症和疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1144435426","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144435426?lang=zh_cn&edition=full","pubTime":"2026-03-03 20:00","pubTimestamp":1772539221,"startTime":"0","endTime":"0","summary":"Harrow Health Inc（纳斯达克代码：HROW）宣布，将启动一项关键的三期临床试验。该试验旨在寻求扩大其核心产品Triesence®的标签适应症范围，计划纳入白内障手术后并发的眼部炎症及疼痛管理。\n若临床试验结果达到预期终点，Triesence®将成为首个获准用于该术后症状的皮质类固醇药物。此举有望为白内障术后患者提供一种新的、有效的治疗选择，并进一步拓宽Triesence®的市场应用空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HROW","BK4007","BK4557"],"gpt_icon":0},{"id":"1101861236","title":"异动解读 | 哈罗制药预计全年收入低于预期，盘前大跌15.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1101861236","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101861236?lang=zh_cn&edition=full","pubTime":"2026-03-03 18:08","pubTimestamp":1772532528,"startTime":"0","endTime":"0","summary":"眼科药品制造商哈罗制药（Harrow Health Inc，股票代码：HROW）今日盘前股价大幅下跌15.66%，引发了市场关注。消息面上，该公司发布了2026年全年收入指引，预计收入在3.5亿美元至3.65亿美元之间，这一数字低于分析师平均预期的3.8625亿美元。不及预期的业绩展望是导致股价下跌的主要原因。尽管该公司第四季度营收为8910万美元，略高于市场预期的8845万美元，但疲弱的全年预测盖过了季度业绩的积极影响，打击了投资者信心，从而在盘前交易中引发了抛售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HROW"],"gpt_icon":0},{"id":"1167371469","title":"财报前瞻 ｜Harrow Health Inc本季度营收预计增43.14%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1167371469","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167371469?lang=zh_cn&edition=full","pubTime":"2026-02-23 10:42","pubTimestamp":1771814534,"startTime":"0","endTime":"0","summary":"Harrow Health Inc将于2026年03月02日盘后发布最新季度财报，市场围绕收入增速与盈利弹性展开关注。市场一致预期本季度Harrow Health Inc营收为8,844.73万USD，同比增43.14%；调整后每股收益为0.37美元，同比增399.66%；同时预计息税前利润为2,305.48万USD，同比增153.58%，由于公开一致预期未提供毛利率与净利润或净利率的预测，相关指标不予展示。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Harrow Health Inc本季度营收预计增43.14%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HROW"],"gpt_icon":0},{"id":"1136172960","title":"Harrow Health Inc重申2025财年营收指引2.7-2.8亿美元，预示将延续强劲增长势头","url":"https://stock-news.laohu8.com/highlight/detail?id=1136172960","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136172960?lang=zh_cn&edition=full","pubTime":"2026-02-02 20:02","pubTimestamp":1770033735,"startTime":"0","endTime":"0","summary":"Harrow Health Inc（纳斯达克：HROW）再次确认了其2025财年的全年营收预期，目标区间锁定在2.7亿至2.8亿美元。这一指引彰显了公司对未来业务持续扩张的坚定信心，预示着其将迎来又一个业绩表现强劲的财年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HROW","BK4557"],"gpt_icon":0},{"id":"2581183618","title":"Harrow, Inc.盘中异动 早盘快速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581183618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581183618?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:43","pubTimestamp":1762526593,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时43分，Harrow, Inc.股票出现波动，股价快速下跌5.08%。Harrow, Inc.股票所在的制药行业中，整体跌幅为1.40%。其相关个股中，Organogenesis Holdings Inc.、Alvotech、Lifecore Biomedical, Inc.涨幅较大，Biofrontera Inc.、Organogenesis Holdings Inc.、Canopy Growth Corporation较为活跃，换手率分别为8.58%、4.07%、3.11%，振幅较大的相关个股有Organogenesis Holdings Inc.、Eton Pharmaceuticals, Inc.、Pacira Biosciences, Inc.，振幅分别为14.91%、13.43%、13.18%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科护理制药公司，从事美国市场眼科药品的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722431394f5ed00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722431394f5ed00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4007","HROW"],"gpt_icon":0},{"id":"2577300660","title":"Harrow, Inc.盘中异动 急速下跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577300660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577300660?lang=zh_cn&edition=full","pubTime":"2025-10-22 23:28","pubTimestamp":1761146915,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日23时28分，Harrow, Inc.股票出现异动，股价大幅下挫5.22%。Harrow, Inc.股票所在的制药行业中，整体涨幅为0.53%。其相关个股中，Bioage Labs, Inc.、Alvotech C/Wts 、Avadel Pharmaceuticals Plc涨幅较大，Shuttle Pharmaceuticals Holdings, Inc.、Avadel Pharmaceuticals Plc、Akanda Corp.较为活跃，换手率分别为61.03%、23.17%、21.41%，振幅较大的相关个股有Alvotech C/Wts 、Incannex Healthcare Inc.、Cardiol Therapeutics Inc.，振幅分别为42.60%、16.14%、14.04%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科护理制药公司，从事美国市场眼科药品的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022232835973cda0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022232835973cda0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","HROW","BK4007"],"gpt_icon":0},{"id":"1141663623","title":"ImprimisRx宣布领导层变更","url":"https://stock-news.laohu8.com/highlight/detail?id=1141663623","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141663623?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:05","pubTimestamp":1759748702,"startTime":"0","endTime":"0","summary":"田纳西州纳什维尔，2025年10月6日——北美领先的眼科疾病管理解决方案提供商Harrow Health Inc今日宣布其全资子公司ImprimisRx的领导层变更。Frank Mullery被任命为首席执行官，Bridseida Cruz被任命为质量主管。Harrow董事长兼首席执行官Mark L. Baum表示：\"我很荣幸Frank和Bridseida在这些高级领导职位上加入ImprimisRx。不应过度依赖前瞻性声明，这些声明仅在作出时有效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HROW","BK4557"],"gpt_icon":0},{"id":"1176370420","title":"Harrow Inc将以430万美元收购Melt剩余股权；达成特定里程碑时将有额外对价——SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1176370420","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176370420?lang=zh_cn&edition=full","pubTime":"2025-09-26 19:10","pubTimestamp":1758885030,"startTime":"0","endTime":"0","summary":"Harrow Inc将以430万美元收购Melt剩余股权；达成特定里程碑时将有额外对价——SEC文件显示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HROW","BK4557"],"gpt_icon":0},{"id":"2569762714","title":"Harrow, Inc.盘中异动 股价大涨5.46%报48.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569762714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569762714?lang=zh_cn&edition=full","pubTime":"2025-09-23 21:32","pubTimestamp":1758634321,"startTime":"0","endTime":"0","summary":"北京时间2025年09月23日21时32分，Harrow, Inc.股票出现异动，股价大幅拉升5.46%。截至发稿，该股报48.61美元/股，成交量5.0821万股，换手率0.14%，振幅1.56%。Harrow, Inc.股票所在的制药行业中，整体跌幅为0.18%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科护理制药公司，从事美国市场眼科药品的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092321320297a4ca46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092321320297a4ca46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","HROW","BK4557"],"gpt_icon":0},{"id":"2518464227","title":"Harrow, Inc.盘中异动 快速下挫5.09%报23.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518464227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518464227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:57","pubTimestamp":1741615071,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时57分，Harrow, Inc.股票出现波动，股价急速下挫5.09%。截至发稿，该股报23.14美元/股，成交量4.036万股，换手率0.11%，振幅2.40%。Harrow, Inc.股票所在的制药行业中，整体跌幅为1.64%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021575198a2a3de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021575198a2a3de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HROW","BK4557","BK4007"],"gpt_icon":0},{"id":"2517195203","title":"Harrow, Inc.盘中异动 下午盘快速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517195203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517195203?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:00","pubTimestamp":1741284006,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时00分，Harrow, Inc.股票出现波动，股价快速下跌5.10%。截至发稿，该股报24.91美元/股，成交量10.25万股，换手率0.29%，振幅4.04%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Harrow, Inc.股票所在的制药行业中，整体跌幅为1.49%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307020006989ed94f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307020006989ed94f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HROW","BK4557","BK4007"],"gpt_icon":0},{"id":"2516087406","title":"Harrow, Inc.盘中异动 早盘快速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516087406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516087406?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:26","pubTimestamp":1741101969,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时26分，Harrow, Inc.股票出现波动，股价快速下跌5.11%。Harrow, Inc.股票所在的制药行业中，整体跌幅为0.38%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Evoke Pharma, Inc.、Citius Oncology, Inc.涨幅较大，大自然药业、Emergent Biosolutions Inc.、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为5.21%、4.86%、4.63%，振幅较大的相关个股有Therapeuticsmd, Inc.、Evoke Pharma, Inc.、Emergent Biosolutions Inc.，振幅分别为18.05%、15.18%、13.76%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030423261096395407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030423261096395407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","HROW","BK4007"],"gpt_icon":0},{"id":"2516658805","title":"Harrow, Inc.盘中异动 早盘大幅下跌5.27%报26.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658805","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658805?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:37","pubTimestamp":1741016264,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时37分，Harrow, Inc.股票出现波动，股价急速下挫5.27%。截至发稿，该股报26.60美元/股，成交量5.4232万股，换手率0.15%，振幅5.91%。Harrow, Inc.股票所在的制药行业中，整体涨幅为0.51%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233744abe64a42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233744abe64a42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","HROW","BK4007"],"gpt_icon":0},{"id":"2513720515","title":"Harrow, Inc.盘中异动 早盘大幅下挫5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720515?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:52","pubTimestamp":1740408779,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时52分，Harrow, Inc.股票出现波动，股价大幅下跌5.15%。Harrow, Inc.股票所在的制药行业中，整体涨幅为0.80%。其相关个股中，Alvotech C/Wts 、Amneal Pharmaceuticals, Inc.、Optinose, Inc.涨幅较大，大自然药业、Petros Pharmaceuticals, Inc.、Therapeuticsmd, Inc.较为活跃，换手率分别为38.79%、8.51%、2.33%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Therapeuticsmd, Inc.、Talphera, Inc.，振幅分别为40.91%、16.15%、9.98%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225259962e9e26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225259962e9e26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HROW","BK4007","BK4557"],"gpt_icon":0},{"id":"2513921587","title":"Harrow, Inc.盘中异动 大幅跳水5.01%报28.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513921587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513921587?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:56","pubTimestamp":1740160584,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时56分，Harrow, Inc.股票出现异动，股价大幅下跌5.01%。截至发稿，该股报28.62美元/股，成交量19.0622万股，换手率0.54%，振幅6.59%。Harrow, Inc.股票所在的制药行业中，整体涨幅为1.43%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015624abd7db10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015624abd7db10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","UPC","HROW","BK4557"],"gpt_icon":0},{"id":"2511486574","title":"Harrow, Inc.盘中异动 下午盘急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511486574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511486574?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:20","pubTimestamp":1739478036,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时20分，Harrow, Inc.股票出现异动，股价大幅拉升5.01%。Harrow, Inc.股票所在的制药行业中，整体涨幅为0.78%。其相关个股中，Cyclo Therapeutics Inc C/Wts 11/12/2025、正业生物、Cyclo Therapeutics, Inc.涨幅较大，大自然药业、Quantum Biopharma Ltd.、Cbdmd, Inc.较为活跃，换手率分别为30.47%、22.90%、16.32%，振幅较大的相关个股有Cyclo Therapeutics Inc C/Wts 11/12/2025、正业生物、Evolus, Inc. Common Stock，振幅分别为28.33%、20.72%、20.44%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214042036abcdf68c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214042036abcdf68c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HROW","BK4557","BK4007"],"gpt_icon":0},{"id":"2511301511","title":"Harrow, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511301511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511301511?lang=zh_cn&edition=full","pubTime":"2025-02-12 23:55","pubTimestamp":1739375733,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日23时55分，Harrow, Inc.股票出现波动，股价大幅跳水5.03%。截至发稿，该股报30.15美元/股，成交量4.4368万股，换手率0.12%，振幅3.81%。Harrow, Inc.股票所在的制药行业中，整体涨幅为0.30%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021223553496208100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021223553496208100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HROW","BK4557","BK4007"],"gpt_icon":0},{"id":"2510633374","title":"Harrow, Inc.盘中异动 早盘股价大跌5.02%报30.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510633374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510633374?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:19","pubTimestamp":1739287165,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时19分，Harrow, Inc.股票出现波动，股价大幅跳水5.02%。截至发稿，该股报30.40美元/股，成交量10.3336万股，换手率0.29%，振幅5.52%。Harrow, Inc.股票所在的制药行业中，整体跌幅为0.38%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231925abcb10e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231925abcb10e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HROW","BK4007","BK4557"],"gpt_icon":0},{"id":"2509068892","title":"Harrow, Inc.盘中异动 早盘大幅上涨5.05%报32.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509068892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509068892?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:19","pubTimestamp":1738858755,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时19分，Harrow, Inc.股票出现异动，股价急速上涨5.05%。截至发稿，该股报32.45美元/股，成交量9.5289万股，换手率0.27%，振幅4.89%。Harrow, Inc.股票所在的制药行业中，整体涨幅为2.13%。Harrow, Inc.公司简介：Harrow Inc 是一家眼科制药公司，致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207001915987c9fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207001915987c9fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4557","HROW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.harrow.com","stockEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.3327},{"period":"3month","weight":-0.2828},{"period":"6month","weight":-0.2494},{"period":"1year","weight":0.1848},{"period":"ytd","weight":-0.3208}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Harrow, Inc.于2006年1月在特拉华州注册成立。该公司是一家领先的眼部护理制药公司，致力于为美国市场发现、开发和商业化创新的眼科医药产品。该公司拥有以Harrow名义销售的大量品牌眼科医药产品组合的商业权利，还经营ImprimisRX，这是一家突出的以眼科为重点的药物复合业务。该公司的目标是让其全面的处方和非处方产品变得容易获得和负担得起，为美国各地的眼部护理专业人员提供支持。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":0.086131},{"month":2,"riseRate":0.615385,"avgChangeRate":0.028046},{"month":3,"riseRate":0.357143,"avgChangeRate":-0.01345},{"month":4,"riseRate":0.538462,"avgChangeRate":0.077573},{"month":5,"riseRate":0.615385,"avgChangeRate":0.08413},{"month":6,"riseRate":0.615385,"avgChangeRate":0.053295},{"month":7,"riseRate":0.538462,"avgChangeRate":0.00412},{"month":8,"riseRate":0.615385,"avgChangeRate":0.069338},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.031108},{"month":10,"riseRate":0.384615,"avgChangeRate":0.007246},{"month":11,"riseRate":0.538462,"avgChangeRate":0.012934},{"month":12,"riseRate":0.5,"avgChangeRate":0.037715}],"exchange":"NASDAQ","name":"Harrow Health Inc","nameEN":"Harrow Health Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Harrow Health Inc(HROW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Harrow Health Inc(HROW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Harrow Health Inc,HROW,Harrow Health Inc股票,Harrow Health Inc股票老虎,Harrow Health Inc股票老虎国际,Harrow Health Inc行情,Harrow Health Inc股票行情,Harrow Health Inc股价,Harrow Health Inc股市,Harrow Health Inc股票价格,Harrow Health Inc股票交易,Harrow Health Inc股票购买,Harrow Health Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Harrow Health Inc(HROW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Harrow Health Inc(HROW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}